Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients

Brain, Behavior, and Immunity

Volumn 22, Issue 6, 2008, Pages 890-900

  Lutgendorf, Susan K ^a,b,c   Lamkin, Donald M ^a   DeGeest, Koen ^b   Anderson, Barrie ^b   Dao, Minh ^d   McGinn, Stephanie ^a   Zimmerman, Bridget ^f   Maiseri, Heena ^a   Sood, Anil K ^e   Lubaroff, David M ^b,c,f,g  

^a E11 SSH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; Cytokines; Depressed mood; Distress; Ovarian cancer; Psychoneuroimmunology; T cell response; Tumor microenvironment

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANXIETY; ARTICLE; ASCITES; CANCER PATIENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IN VIVO STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE;

AGED; ANXIETY; CELLS, CULTURED; CYTOKINES; DEPRESSION; FEMALE; HUMANS; IMMUNITY; INTERFERON TYPE I; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MIDDLE AGED; OVARIAN NEOPLASMS; QUESTIONNAIRES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 46049102610     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.12.012     Document Type: Article

References (61)

1. American Cancer Society, 2007. Cancer facts and figures. Atlanta, GA.
2. Andersen B., Anderson B., and deProsse C. Controlled prospective longitudinal study of women with cancer: I. Psychological functioning and outcomes. J. Consult. Clin. Psychol. 57 (1989) 683-691
3. Andersen B., Farrar W.B., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., and Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst. 90 (1998) 30-36
4. Andersen B., Farrar W.B., Golden-Kreutz D.M., Glaser R., Emery C.F., Crespin T.R., Shapiro C.L., and Carson W.E. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol. 22 (2004) 3570-3580
5. Antoni M., Cruess D., Wagner S., Lutgendorf S., Kumar M., Ironson G., Klimas N., Fletcher M., and Schneiderman N. Cognitive behavioral stress management reduces anxiety and 24-hour urinary catecholamine output among symptomatic HIV-infected gay men. J. Consult. Clin. Psychol. 66 (2000) 31-45
6. Antoni M., Cruess S., Cruess D., Kumar M., Lutgendorf S., Ironson G., Dettmer E., Williams J., Klimas N., Fletcher M., and Scheiderman N. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men. Ann. Behav. Med. 22 (2000) 29-37
7. Badger A., Oh S., and Moolten F. Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody dependent cytotoxicity. Cancer Res. 41 (1981) 1133-1139
8. Berek J.S., Bast R.C., and Lichtenstein A. Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer. Obstet. Gynecol. 64 (1984) 708-714
9. Chen C., Wu M., Chao K., Ho H., Sheu B., and Huang S. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies. J. Formos. Med. Assoc. 98 (1999) 24-30
10. Chrousos G. The concepts of stress and stress system disorders. JAMA 267 (1992) 1244-1252
11. Conticello C., Pedini F., Zeuner A., Patti M., Zerilli M., Stassi G., Messina A., Peschle C., and De Maria R. IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins. J. Immunol. 172 (2004) 5467-5477
12. Curran S.L., Andrykowski M.A., and Studts J.L. Short form of the profile of mood states (POMS-SF): psychometric information. Psychol. Assess. 7 (1995) 80-83
13. Dobrzanski M.J., Reome J.B., and Dutton R.W. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases. J. Immunol. 162 (1999) 6671-6680
14. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann. N. Y. Acad. Sci. 1024 (2004) 138-146
15. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 10 (1999) 359-368
16. Elenkov I.J., and Chrousos G.P. Neuroendocrine regulation of IL-12 and TNFalpha/IL-10 balance: clinical implications. Ann. N. Y. Acad. Sci. 917 (2000) 94-105
17. Elenkov I.J., Papanicolaou D.A., Wilder R.L., and Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Phys. 108 (1996) 374-381
18. Garzetti G., Cignitti M., Ciavattini A., Fabris N., and Romanini C. Natural killer cell activity and progression-free survival in ovarian cancer. Gynecol. Obstet. Invest. 35 (1993) 118-120
19. Glaser R., MacCallum R., Laskowski B., Malarkey W., Sheridan J., and Kiecolt-Glaser J. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J. Gerontol. A. Biol. Sci. Med. Sci. 56 (2001) M477-M482
20. Goedegebuure P., Douville C.C., Doherty J.M., Linehan D.C., Lee K.Y., Ganguly E.K., and Eberlein T.J. Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. Cell. Immunol. 175 (1997) 150-156
21. Harada Y., Watanabe S., Yssel H., and Arai K. Factors affecting the cytokine production of human T cells stimulated by different modes of activation. J. Allergy Clin. Immunol. 98 (1996) S161-S173
22. Heilig M., Irwin M., Grewal I., and Sercarz E. Sympathetic regulation of T-helper cell function. Brain Behav. Immun. 7 (1993) 154-163
23. Hughes J.W., Watkins L., Blumenthal J.A., Kuhn C., and Sherwood A. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J. Psychosom. Res. 57 (2004) 353-358
24. Ioannides C., Freedman R., Platsoucas C., Rashed S., and Kim Y. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J. Immunol. 146 (1991) 1700-1707
25. Irwin M. Immune correlates of depression. Adv. Exp. Med. Biol. 461 (1999) 1
26. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav. Immun. 16 (2002) 1-16
27. Irwin M.R., and Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21 (2007) 374-383
28. Kalinichenko V.V., Mokyr M.B., Graf L.H.J., Cohen R.L., and Chambers D.A. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J. Immunol. 163 (1999) 2492-2499
29. Kelso A. Educating T cells: early events in the differentiation and commitment of cytokine-producing CD4+ and CD8+ T cells. Springer Semin. Immunopathol. 21 (1999) 231-248
30. Kemp R.A., and Ronchese F. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J. Immunol. 167 (2001) 6497-6502
31. King C., Mueller Hoenger R., Malo Cleary M., Murali-Krishna K., Ahmed R., King E., and Sarvetnick N. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat. Med. 7 (2001) 206-214
32. Koga C., Itoh K., Aoki M., Suefuji Y., Yoshida M., Asosina S., Esaki K., and Kameyama T. Anxiety and pain suppresses the natural killer cell activity in oral surgery outpatients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 91 (2001) 654-658
33. Kooi S., Freedman R., Rodriguez-Villanueva J., and Platsoucas C. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells. Lymphokine Cytokine Res. 12 (1993) 429-437
34. Lai P., Rabinowich H., Crowley-Nowick P., Bell M., Mantovani G., and Whiteside T. Alteration in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin. Cancer Res. 2 (1996) 161-173
35. Lockhart D.C., Chan A.K., Mak S., Joo H.G., Daust H.A., Carritte A., Douville C.C., Goedegebuure P.S., and Eberlein T.J. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma. Surgery 129 (2001) 749-756
36. Lutgendorf S., Sood A.K., Anderson B., McGinn S., Maiseri H., Dao M., Sorosky J., DeGeest K., Ritchie J., and Lubaroff D.M. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J. Clin. Oncol. 23 (2005) 7106-7113
37. Maier S. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav. Immun. 17 (2003) 69-85
38. Maier S., and Watkins L. Cytokines for psychologists: Implications of bidirectional immune to brain communication for understanding behavior, mood, and cognition. Psychol. Rev. 105 (1998) 83-107
39. Marth C., Fiegl H., Zeimet A.G., Muller-Holzner E., Deibl M., Doppler W., and Daxenbichler G. Interferon-gamma expression is an independent prognostic factor in ovarian cancer. Am. J. Obstet. Gynecol. 191 (2004) 1598-1605
40. Martinez O.M., Gibbons R.S., Garovoy M.R., and Aronson F.R. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J. Immunol. 144 (1990) 2211-2215
41. Mattes J., Hulett M., Xie W., Hogan S., Rothenberg M.E., Foster P., and Parish C. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J. Exp. Med. 197 (2003) 387-393
42. Mausbach B.T., Dimsdale J.E., Ziegler M.G., Mills P.J., Ancoli-Israel S., Patterson T.L., and Grant I. Depressive symptoms predict norepinephrine response to a psychological stressor task in Alzheimer's caregivers. Psychosom. Med. 67 (2005) 638-642
43. McGregor B., Antoni M., Boyers A., Alferi S., Blomberg B., and Carver C. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J. Psychosom. Res. 56 (2004) 1-8
44. Nakada M.T., Stadel J.M., Poksay K.S., and Crooke S.T. Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes. Mol. Pharmacol. 31 (1987) 377-384
45. Olver S., Groves P., Buttigieg K., Morris E., Janas M., Kelso A., and Kienzle N. Tumor-derived interleukin-4 reduces tumor clearance and deviates the cytokine and granzyme profile of tumor-induced CD8+ T cells. Cancer Res. 66 (2006) 571-580
46. Rabinowich H., Suminami Y., Reichert T.E., Crowley-Nowick P., Bell M., Edwards R., and Whiteside T.L. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma. Int. J. Cancer 68 (1996) 276-284
47. Raspollini M.R., Castiglione F., Rossi Degl'innocenti D., Amunni G., Villanucci A., Garbini F., Baroni G., and Taddei G.L. Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. Ann. Oncol. 16 (2005) 590-596
48. Reiche E.M., Nunes S.O., and Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol. 5 (2004) 617-625
49. Rodolfo M., Zilocchi C., Accornero P., et al. IL-4-transduced tumor cell vaccine induces immunoregulatiory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer. J. Immunol. 163 (1999) 1923-1928
50. Sacham S. A shortened version of the Profile of Mood States. J. Pers. Assess. 47 (1983) 305-306
51. Santin A.D., Bellone S., Palmieri M., Bossini B., Cane S., Bignotti E., Roman J.J., Cannon M.J., and Pecorelli S. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer. Int. J. Gynecol. Cancer 14 (2004) 64-75
52. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004) 601-630
53. Snijders T.A., and Bosker R.J. Multilevel analysis: an introduction to basic and advanced multilevel modeling (1999), Sage, London
54. Stassi G., Todaro M., Zerilli M., Ricci-Vitiani L., Di Liberto D., Patti M., Florena A., Di Gaudio F., Di Gesu G., and De Maria R. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res. 63 (2003) 6784-6790
55. Takashi N., Iwakabe K., Sekimoto M., et al. Distinct role of antigen-specific T helper Type 1 (Th1) and Th2 cells in tumor eradication in vivo. J. Exp. Med. 190 (1999) 617-624
56. Tanaka T., Hu-Li J., Seder R.A., Fazekas de St Groth B., and Paul W.E. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5914-5918
57. Thornton L.M., Andersen B.L., Crespin T.R., and Carson W.E. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav. Immun. 21 (2007) 185-194
58. VanTits L., and Graafsma S. Stress influences CD4+ lymphocyte counts. Immunol. Lett. 30 (1991) 141-142
59. Yamada A., Kawano K., Harashima N., Niiya F., Nagai K., Kobayashi T., Mine T., Ushijima K., Nishida T., and Itoh K. Study of HLA class 1 restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer. Cancer Immunol. Immunother. 48 (1999) 147
60. Zea A., Curti B., Longo D., Alvord W., Strobl S., Mizoguchi H., Creekmore S., O'Shea J., Powers G., and Urba W. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res. 1 (1995) 1327-1335
61. Zhang L., Conejo-Garcia J.R., Katsaros D., Gimotty P.A., Massobrio M., Regnani G., Makrigiannakis A., Gray H., Schlienger K., Liebman M.N., Rubin S.C., and Coukos G. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Eng. J. Med. 348 (2003) 203-213